Different bacteriology and prognosis of thoracic empyemas between patients with chronic and end-stage renal disease

Chest

Volumn 132, Issue 2, 2007, Pages 532-539

  Chen, Chia Hung ^a   Hsu, Wu Huei ^a   Chen, Hung Jen ^a   Chen, Wei ^a   Shih, Chuen Ming ^a   Hsia, Te Chun ^a   Tu, Chih Yen ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bacteriology; Chronic kidney disease; Empyema; End stage renal disease

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM CULTURE; CHRONIC DISEASE; CONTROLLED STUDY; DIALYSIS; FEMALE; GRAM NEGATIVE ANAEROBIC BACTERIA; HUMAN; KIDNEY FAILURE; KLEBSIELLA PNEUMONIAE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PLEURA EMPYEMA; PLEURA FLUID; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; UNIVERSITY HOSPITAL;

EID: 34548021678     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-0005     Document Type: Article

References (24)

1. Pesanti EL. Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am 2001; 15:813-832
2. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001; 120:1883-1887
3. Berman SJ, Johnson EW, Nakatsu C, et al. Burden of infection in patients with end-stage renal disease requiring long-term dialysis. Clin Infect Dis 2004; 39:1747-1753
4. Richard EB, Christopher JS. Pleural empyema. Clin Infect Dis 1996; 22:747-764
5. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266
6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41
7. Light RW. A new classification of parapneumonic effusions and empyema. Chest 1995; 108:299-301
8. Soo Hoo GW, Wen YE, Nguyen TV, et al. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest 2005; 128:2778-2787
9. Mermel L, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32:1249-1272
10. Brook I, Frazier EH. Aerobic and anaerobic microbiology of empyema: a retrospective review in two military hospitals. Chest 1993; 103:1502-1507
11. Varkey B, Rose HD, Kutty CP, et al. Empyema thoracis during a ten-year period: analysis of 72 cases and comparison to a previous study (1952-1967). Arch Intern Med 1981; 141:1771-1776
12. Smith JA, Mullerworth MH, Westlake GW, et al. Empyema thoracis: a 14-year experience in a teaching center. Ann Thorac Surg 1991; 51:39-42
13. Albrecht SJ, Fishman NO, Kitchen J, et al. Reemergence of Gram-negative health care-associated bloodstream infections, Arch Intern Med 2006; 166:1289-1294
14. Vianna NJ. Nontuberculous bacterial empyema in patients with and without underlying disease. JAMA 1971; 215:69-75
15. Kessler M, Hoen B, Mayeux D, et al. Bacteremia in patients on chronic hemodialysis: a multicenter prospective survey. Nephron 1993; 64:9.5-100
16. Hoen B, Kessler M, Hestin D, et al. Risk factors for bacterial infections in chronic hemodialysis adult patients: a multicentre prospective survey. Nephrol Dial Transplant 1995; 10:377-381
17. Hoen B, Paul-Dauphin ADH, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9:869-876
18. Maskell NA, Davies CWH, Nunn AJ, et al. UK controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352:865-874
19. Maskell NA, Batt S, Emma LH, et al: the bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006; 174:817-823
20. Bouros D, Schiza S, Tzanakis N, et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double-blind study. Am J Respir Crit Care Med 1999; 159:37-42
21. Bouros D, Schiza S, Tzanakis N, et al. Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema. Eur Respir J 1996; 9:1656-1659
22. Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-155
23. Leibovici L, Shraga I, Drucker M, et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244:379-386
24. Kollef MH, Sherman C, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474